VERTEX PHARMACEUTICALS INC (VX1.DE) Stock Analyst Ratings
FRA:VX1 - Deutsche Boerse Ag - US92532F1003 - Common Stock - Currency: EUR
ChartMill assigns a Buy % Consensus number of 77% to VX1.DE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 476.98. This target is 3.8% above the current price.
VX1.DE was analyzed by 40 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about VX1.DE.
In the previous month the buy percentage consensus was at a similar level.
VX1.DE was analyzed by 40 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-07-30 | RBC Capital | Maintains | Outperform |
| 2021-07-30 | SVB Leerink | Maintains | Underperform |
| 2021-07-30 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-07-30 | Piper Sandler | Maintains | Overweight |
| 2021-07-20 | SVB Leerink | Downgrade | Market Perform -> Underperform |
| 2021-07-01 | Raymond James | Initiate | Market Perform |
| 2021-06-14 | SVB Leerink | Maintains | Market Perform |
| 2021-06-14 | Truist Securities | Maintains | Buy |
| 2021-06-14 | Piper Sandler | Maintains | Overweight |
| 2021-06-11 | Cantor Fitzgerald | Maintains | Overweight |
| 2021-06-11 | RBC Capital | Maintains | Outperform |
| 2021-06-11 | Stifel | Maintains | Buy |
| 2021-06-11 | Barclays | Maintains | Overweight |
| 2021-06-11 | Baird | Maintains | Outperform |
| 2021-06-11 | Goldman Sachs | Maintains | Buy |
| 2021-06-11 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-06-11 | Citigroup | Maintains | Buy |
| 2021-04-30 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-04-19 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-02-23 | Baird | Upgrade | Neutral -> Outperform |